TimesSquare Capital Management’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,192,660
| Closed | -$15M | – | 187 |
|
|
2023
Q1 | $15M | Sell |
1,192,660
-236,650
| -17% | -$2.97M | 0.22% | 143 |
|
|
2022
Q4 | $21M | Sell |
1,429,310
-90,600
| -6% | -$1.33M | 0.3% | 129 |
|
|
2022
Q3 | $26M | Buy |
1,519,910
+38,200
| +3% | +$654K | 0.36% | 125 |
|
|
2022
Q2 | $21.6M | Buy |
1,481,710
+822,110
| +125% | +$12M | 0.3% | 131 |
|
|
2022
Q1 | $11.1M | Sell |
659,600
-1,200
| -0.2% | -$20.2K | 0.12% | 167 |
|
|
2021
Q4 | $14.9M | Buy |
660,800
+10,020
| +2% | +$225K | 0.13% | 175 |
|
|
2021
Q3 | $14M | Sell |
650,780
-35,925
| -5% | -$774K | 0.12% | 192 |
|
|
2021
Q2 | $19.9M | Buy |
686,705
+234,805
| +52% | +$6.8M | 0.16% | 180 |
|
|
2021
Q1 | $14.6M | Sell |
451,900
-12,700
| -3% | -$409K | 0.12% | 186 |
|
|
2020
Q4 | $19.2M | Buy |
+464,600
| New | +$19.2M | 0.16% | 181 |
|